Location History:
- Neuallschwil, CH (1976 - 1977)
- Allschwil, CH (1976 - 1986)
Company Filing History:
Years Active: 1976-1986
Title: Atso Ilvespaa: Innovator in Pharmaceutical Chemistry
Introduction
Atso Ilvespaa is a notable inventor located in Allschwil, Switzerland, recognized for his contributions to pharmaceutical chemistry. With an impressive portfolio of nine patents, he has focused on developing innovative solutions that address critical health issues, including allergies and diabetes.
Latest Patents
Among Atso's latest patents are the "Anti-allergic 3-(carboxycarbonyl)amino benzothiopyran-4-one derivatives." This invention features novel thiopyrones, particularly benzothiopyranones, characterized by a general formula that includes aliphatic radicals and other functional groups. These compounds exhibit anti-allergic properties and can be utilized as active ingredients in pharmaceutical preparations.
Another significant patent is related to "Guanidine compounds, pharmaceutical compositions and use." This invention covers guanidine derivatives with hypoglycaemic activity, aimed at providing oral treatment for hyperglycaemia in mammals, particularly for managing Diabetes mellitus. This invention represents a critical advancement in the treatment options available for diabetes.
Career Highlights
Atso Ilvespaa is associated with Ciba-Geigy Corporation, a prominent name in the pharmaceutical industry. His work has contributed to the company's efforts in developing innovative drug solutions that improve patient care. Over the course of his career, Atso has focused on creating compounds that provide tangible benefits for health-related applications.
Collaborations
Throughout his innovative journey, Atso has collaborated with skilled colleagues such as Jorg Frei and Ernst Schweizer. These collaborations have enhanced the development of his patents, fostering a creative environment that promotes scientific advancements in pharmaceutical chemistry.
Conclusion
Atso Ilvespaa's dedication to innovation in pharmaceutical chemistry exemplifies the impact inventors can have on improving health outcomes. His work on anti-allergic compounds and guanidine derivatives highlights his role in addressing critical medical challenges. With a strong foundation in research and collaboration, Atso continues to be a significant contributor to the field of pharmaceuticals.